Tezspire (tezepelumab-ekko) is a monthly injection used to treat severe asthma. It was approved by the FDA in 2021 for use in addition to other asthma controlling medicines in people 12 and older.

Asthma care continues to develop, particularly in how treatment and long-term management are approached. This article outlines current treatment and management recommendations for patients aged 12 and ...

Scientists working in the School of Biochemistry and Immunology at the Trinity Biomedical Sciences Institute (TBSI) report they have uncovered a new strategy in mice for treating severe asthma. The ...

Asthma in older age is associated with significantly higher rates of depression, cognitive decline, and multimorbidity.

Allergies are one of the most common, but overlooked, conditions. With Spring in full swing, it's important to know the facts ...

Black and Latinx patients bear a disproportionate burden of asthma. Efforts to reduce the disproportionate morbidity have been mostly unsuccessful, and guideline recommendations have not been based on ...

Globally, 262 million patients are diagnosed with asthma as of 2019, while in India, the asthma rate is at 2,241 per 100,000. These figures, according to the World Population Review, are significantly ...

Though they’re separate conditions, allergic rhinitis and asthma are both atopic diseases. Allergies can trigger asthma, and having asthma can increase your risk for allergic rhinitis. Allergic ...